Omeprazole preferentially inhibits the metabolism of (+)-(S)-citalopram in healthy volunteers (2010)
- Authors:
- USP affiliated authors: ROCHA, ADRIANA - FCFRP ; COELHO, EDUARDO BARBOSA - FMRP ; LANCHOTE, VERA LUCIA - FCFRP
- Unidades: FCFRP; FMRP
- DOI: 10.1111/j.1365-2125.2010.03649.x
- Assunto: FARMACOCINÉTICA
- Language: Inglês
- Imprenta:
- Source:
- Título: British Journal of Clinical Pharmacology
- ISSN: 0306-5251
- Volume/Número/Paginação/Ano: v. 70, n. 1, p. 43-51, 2010
- Status:
- Artigo possui acesso gratuito no site do editor (Bronze Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
ROCHA, Adriana et al. Omeprazole preferentially inhibits the metabolism of (+)-(S)-citalopram in healthy volunteers. British Journal of Clinical Pharmacology, v. 70, n. 1, p. 43-51, 2010Tradução . . Disponível em: https://doi.org/10.1111/j.1365-2125.2010.03649.x. Acesso em: 01 abr. 2026. -
APA
Rocha, A., Coelho, E. B., Sampaio, S. A., & Lanchote, V. L. (2010). Omeprazole preferentially inhibits the metabolism of (+)-(S)-citalopram in healthy volunteers. British Journal of Clinical Pharmacology, 70( 1), 43-51. doi:10.1111/j.1365-2125.2010.03649.x -
NLM
Rocha A, Coelho EB, Sampaio SA, Lanchote VL. Omeprazole preferentially inhibits the metabolism of (+)-(S)-citalopram in healthy volunteers [Internet]. British Journal of Clinical Pharmacology. 2010 ; 70( 1): 43-51.[citado 2026 abr. 01 ] Available from: https://doi.org/10.1111/j.1365-2125.2010.03649.x -
Vancouver
Rocha A, Coelho EB, Sampaio SA, Lanchote VL. Omeprazole preferentially inhibits the metabolism of (+)-(S)-citalopram in healthy volunteers [Internet]. British Journal of Clinical Pharmacology. 2010 ; 70( 1): 43-51.[citado 2026 abr. 01 ] Available from: https://doi.org/10.1111/j.1365-2125.2010.03649.x - Omeprazole inhibits preferentially the metabolism of the (+)-(S)-citalopram eutomer in healthy volunteers
- Investigation of the in vivo activity of CYP3A in Brazilian volunteers: comparison of midazolam and omeprazole as drug markers
- LC-MS/MS analysis of the plasma concentrations of a cocktail of 5 cytochrome P450 and P-glycoprotein probe substrates and their metabolites using subtherapeutic doses
- Influence of quinidine, fluvoxamine, and ketoconazole on the enantioseletive pharmacokinetics of citalopram in rats
- Enantioselectivity in the pharmacokinetic interaction between fluvastatin and lercanidipine in healthy volunteers
- Influence of type-2 diabetes mellitus on the stereoselective kinetic disposition of fluvastatin
- Stereoselective analysis of metoprolol and its metabolites inrat plasma with application to oxidative metabolism
- Effects of type 2 diabetes mellitus in patients on treatment with glibenclamide and metformin on carvedilol enantiomers metabolism
- Effect of hypertension on the stereoselective pharmacokinetics of fluvastatin in rats
- Lercanidipine-fluvastatin interaction: pharmacokinetics stereoselectivity in experimental study
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
